Ringer lactate similar to standard salt solution

Article

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

Ringer lactate similar to standard salt solution

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

A team led by Dr Barun K. Nayak, Hinduja Hospital, Veer Sawarkar Marg, Mahim, Mumbai, India, conducted a prospective randomized controlled double-blinded clinical study on 75 eyes of 75 patients with senile cataract up to nuclear grade III. All patients were randomized to receive a fortified balanced salt solution (Group A) or Ringer lactate (Group B) as an intraocular irrigating solution.

Corneal endothelial cell density was the primary outcome and pachymetry was recorded preoperatively and one week and one and six months after treatment.

The results revealed no significant difference in postoperative percentage of endothelial cell loss between the two groups at one week, one month and 6 month follow-ups.

Postoperative percentage change in pachymetry was not significant between the two groups at the one week or one month follow-ups but there was a significant difference at the six-month follow-up.

The abstract was published in the Journal of Cataract and Refractive Surgery .

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.